Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events

This publication has 16 references indexed in Scilit:

• Application of U.S. guidelines in other countries: Aspirin for the primary prevention of cardiovascular events in Japan
  The American Journal of Medicine, 2004
• AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update
  Circulation, 2002
• Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force
  Annals of Internal Medicine, 2002
• Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rationale
  Annals of Internal Medicine, 2002
• Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials
  Heart, 2001
• Primary Prevention of Coronary Heart Disease
  Circulation, 1999
• Aspirin and Risk of Hemorrhagic Stroke
  JAMA, 1998
• Prediction of Coronary Heart Disease Using Risk Factor Categories
  Circulation, 1998
• Mortality by cause for eight regions of the world: Global Burden of Disease Study
  Published by Elsevier ,1997
• Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
  New England Journal of Medicine, 1989